Trial NCT02044822

View at ClinicalTrials.gov 
Org. Study IDs: GS-US-312-0133
Secondary IDs: 2013-003314-41

Last trial update was posted on 2018-11-19

MeSH Interventions

Idelalisib Rituximab

MeSH Conditions

Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid

Other Conditions

B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion

Stopping Reasons

N/A

Limitations And Caveats

Due to the early termination of the study, efficacy data were not available for all participants, and therefore the prespecified analyses were not conducted.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID